½ÉÇÏÁö ¾ÊÀº ¿ì¿ïÁõ¿¡¼´Â SSRI »ç¿ëÀÌ placebo¿Í ºñ±³Çؼ µµ¿òÀÌ µÇÁö ¾Ê´Â´Ù°í JAMA¿¡ ¹ßÇ¥µÇ¾ú½À´Ï´Ù. ±×¸®°í Ç׿ì¿ïÁ¦ÀÇ »ç¿ëÀÌ Á¾·ù¿¡ °ü°è¾øÀÌ ÀÚ»ì À§ÇèÀ» ³ôÀÏ ¼ö ÀÖÀ¸¹Ç·Î ÁÖÀÇ°¡ ÇÊ¿äÇÏ´Ù°í ÇÕ´Ï´Ù. Ç׿ì¿ïÁ¦¸¦ »ç¿ëÇÏ´Â ºÐµéÀº f/uÀ» ÀÚÁÖ ÇÏ°í ÀÚ»ìÀÇ À§ÇèÀ» ¹Ýº¹Æò°¡ÇØ¾ß ÇÕ´Ï´Ù. Ç׿ì¿ïÁ¦ »ç¿ëÇÏ´Ù°¡ f/u loss µÈ ºÐµéÀÌ ¾î¶»°Ô Áö³»°í ÀÖ´ÂÁö È®ÀÎÀÌ ÇÊ¿äÇÕ´Ï´Ù. JAMA. 2010 Jan 6;303(1):47-53. Antidepressant drug effects and depression severity: a patient-level meta-analysis. Arch Gen Psychiatry. 2010 May;67(5):497-506. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. Treatment decisions should be based on efficacy, and clinicians should be vigilant in monitoring after initiating therapy with any antidepressant agent.